# Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma

> **NCT01498783** · PHASE1 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 26 (actual)

## Conditions studied

- Central Nervous System Malignancies
- Ependymoma

## Interventions

- **DRUG:** 5-fluorouracil

## Key facts

- **NCT ID:** NCT01498783
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2016-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01498783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01498783, "Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01498783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*